157 related articles for article (PubMed ID: 17667557)
21. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's disease in a patient with Von Hippel-Lindau disease. A case report.
D'hondt R; Thomas J; Van Oosterom AT; Dewolf-Peeters C
Acta Clin Belg; 2000; 55(5):276-8. PubMed ID: 11109642
[TBL] [Abstract][Full Text] [Related]
23. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
24. A detailed immunohistochemical analysis of 2 cases of papillary cystadenoma of the broad ligament: an extremely rare neoplasm characteristic of patients with von hippel-lindau disease.
Brady A; Nayar A; Cross P; Patel A; Naik R; Lee S; Kaushik S; Barton D; McCluggage WG
Int J Gynecol Pathol; 2012 Mar; 31(2):133-40. PubMed ID: 22317868
[TBL] [Abstract][Full Text] [Related]
25. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.
Esteban MA; Harten SK; Tran MG; Maxwell PH
J Am Soc Nephrol; 2006 Jul; 17(7):1801-6. PubMed ID: 16775032
[TBL] [Abstract][Full Text] [Related]
26. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred.
Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K
Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570
[TBL] [Abstract][Full Text] [Related]
27. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
28. Bilateral Scrotal Masses as a Clue to Diagnosis of Genetic Disease.
Saowapa S; Ativitavas T; Sriphrapradang C
Am J Med Sci; 2020 Apr; 359(4):250-251. PubMed ID: 31902518
[No Abstract] [Full Text] [Related]
29. von Hippel-Lindau disease: genetic, clinical, and imaging features.
Choyke PL; Glenn GM; Walther MM; Patronas NJ; Linehan WM; Zbar B
Radiology; 1995 Mar; 194(3):629-42. PubMed ID: 7862955
[TBL] [Abstract][Full Text] [Related]
30. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma.
Aydin H; Young RH; Ronnett BM; Epstein JI
Am J Surg Pathol; 2005 Apr; 29(4):520-3. PubMed ID: 15767808
[TBL] [Abstract][Full Text] [Related]
31. Novel human pathological mutations. Gene symbol: VHL. Disease: Von Hippel-Lindau syndrome.
Castellano M
Hum Genet; 2009 Aug; 126(2):340. PubMed ID: 19694021
[No Abstract] [Full Text] [Related]
32. Paratesticular Papillary Cystadenoma of the Epididymis in the Setting of von Hippel-Lindau.
Gupta S; Erickson LA
Mayo Clin Proc; 2021 Mar; 96(3):828-829. PubMed ID: 33673939
[No Abstract] [Full Text] [Related]
33. Papillary cystadenoma of the epididymis: a case report.
Lissens P; Michiels H; Geysens P; Van de Voorde W; Lauweryns J
Acta Urol Belg; 1995 Mar; 63(1):109-12. PubMed ID: 7725985
[TBL] [Abstract][Full Text] [Related]
34. Germline VHL gene mutations in three Serbian families with von Hippel-Lindau disease.
Stanojevic BR; Lohse P; Neskovic GG; Damjanovic SM; Novkovic TB; Jovanovic-Cupic SP; Dimitrijević BB
Neoplasma; 2007; 54(5):402-6. PubMed ID: 17688370
[TBL] [Abstract][Full Text] [Related]
35. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
[TBL] [Abstract][Full Text] [Related]
36. Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cystadenoma. Manifestations of von Hippel-Lindau disease.
Gaffey MJ; Mills SE; Boyd JC
Am J Surg Pathol; 1994 Dec; 18(12):1254-60. PubMed ID: 7977949
[TBL] [Abstract][Full Text] [Related]
37. Pheochromocytoma as the first manifestation of von Hippel-Lindau disease.
Richard S; Beigelman C; Duclos JM; Fendler JP; Plauchu H; Plouin PF; Resche F; Schlumberger M; Vermesse B; Proye C
Surgery; 1994 Dec; 116(6):1076-81. PubMed ID: 7985090
[TBL] [Abstract][Full Text] [Related]
38. [Papillary cystadenoma of the epididymis revealing von Hippel-Lindau disease].
Handra-Luca A; Toublanc M; Richard S; Polivka M; Boccon-Gibod L; Hénin D
Ann Pathol; 2001 Feb; 21(1):102-3. PubMed ID: 11223573
[No Abstract] [Full Text] [Related]
39. von Hippel-Lindau disease: epididymal cystadenoma targeted by metastatic events.
Mehta GU; Shively SB; Gläsker S; Bechert CJ; Zhuang Z; Raffeld M; Lonser RR; Oldfield EH; Vortmeyer AO
Urology; 2007 Jun; 69(6):1209.e9-12. PubMed ID: 17572225
[TBL] [Abstract][Full Text] [Related]
40. Expression of vascular endothelial growth factor in von Hippel-Lindau syndrome-associated papillary cystadenoma of the epididymis.
Leung SY; Chan AS; Wong MP; Yuen ST; Fan YW; Chung LP
Hum Pathol; 1998 Nov; 29(11):1322-4. PubMed ID: 9824115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
